Advancements in Stents Composition Material Has Encouraged Ureteral Stents Market to Proliferate at a CAGR of 8%, Finds MRFR
According to the new reports published by Market Research Future Reports, the Global Ureteral Stents Market Share is encouraged to proliferate at a CAGR of 8% owing to advancements in stents composition material and more factors.
Ureteral stents are mainly used to aid urine drainage from blocked ureters. Various cases of urological disorders are recorded such as kidney stones, tumors, and kidney transplantation which require proper medication. Ureteral stents aid in the best manner in such cases, due to which, presently, the market of ureteral stents is expanding at a higher CAGR. Stents are also being used in in the cases of a scratched ureter which might be an effect of ureteroscopy. Any surgery on the ureter generally requires a stent to allow proper healing of the ureter.
Key Players
Market Research Future Reports have also mentioned the top listed market key players, those names are Boston Scientific Corporation (US), Cook Medical, Inc. (US), C. R. Bard, Inc. (US), Medline Industries, Inc. (US), Allium Medical Solutions Ltd (Israel), Pnn Medical A/S (Denmark), B. Barun melsungen (Germany), Urovision (Germany), Surgimedik, Coloplast (Denmark), Applied Medical (US), Teleflex (US), Urotech, Opti-Med, Goharshafa, Mednova, ConMed, W. L. Gore & Associates Inc., Merit Endotek, Micro-Tech Co., Ltd, Rontis Medical, Smiths Medical and many more.
Global Ureteral Stents Market: Drivers & Trends
The essential factors that are leading the global ureteral stents market are noted to be as constant technological developments, rise in urological diseases, and an increase in medical tourism in developing countries. These are attributing to the growth of the market in positive ways. Some other prominent factors requiring the need for ureteral stents can be for prostate cancer and tumors or narrowing of the ureter or damage on the wall of ureter. With the rising incidence of these conditions, the ureteral stents market is anticipated to cultivate at a significant CAGR over the forecast period.
Going forward, another key contributor to the growth of global ureteral stents include mounting numbers of urological procedures owing to the inactive lifestyle of the people coupled with expanding the elderly population. It has been observed that a large number of people are variably into poor dietary habits which are increasing obesity levels and rising cases of metabolic disorders. These are also significant factors that are fueling the market in positive ways. With that, advancements in stents composition materials are to minimize discomfort within patients, robust stent design and construction is expected to favor the market to expand.
Most importantly, the availability of innovative smartphone applications has boosted the growth of the ureteral stents market. This is appreciable for safety o patients, which are altogether useful for both physicians and patients.
On the flip side, the complicated procedure of placement od stent, lack of skilled surgeons, complications after removal of the stent creating discomfort and side effects such as increased frequency of passing urine and urgency to pass urine are becoming the major restraints for ureteral stents market growth.
Market Segmentation
According to MRFR’s reports, the global ureteral stents market has been segmented by the type into open end stents, double pigtail stents, closed-end stents, multiloop stents.
By the segmentation of type of material, this market is segmented into metal stents, silicone stents, plastic stents, hydrogel stents, polyurethane stents and other.
By the segmentation of application, the market is segmented into ureterorenoscopy, lithotripsy, and others.
Regional Analysis
According to the geographical segmentation, the global ureteral stent market is thus diversified into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, and the Middle East and Africa.
The developed markets in North America is expecting to witness rapid growth throughout the forecast period owing to the factors contributing are the presence of the prominent market players and rise in the number of urological surgeries, and continuous research and development in the projects. Also, with the presence of well-established healthcare systems, the market is spurring at a higher CAGR due to the increase in diseases such as kidney stones and tumors. In addition, a higher adoption rate for technologically advanced devices has also ignited the new growth measure for ureteral stent market.
However, Asia Pacific will also have growth in the forecast period owing to emerging healthcare infrastructure and favorable treatments available for patients. Whereas, the Middle East region have hospitals that are providing better services in the urology.
